Evaluation of the Naturalistic User Experience of the Website "ich Bin Alles"

October 30, 2024 updated by: Ellen Greimel, Ludwig-Maximilians - University of Munich

Evaluation of the Naturalistic User Experience of the Website "ich Bin Alles" - an Information Platform for Children and Adolescents with and Without Depression and Their Relatives

Using a multi-method approach, the aim of this study is to investigate the naturalistic user experience and acceptance of the German website "ich bin alles". This website offers evidence-based information about the symptoms, causes, course, treatment, and prevention of youth depression. Another aim of this study is to determine whether the desired target groups of the website can be reached.

Study Overview

Detailed Description

Depressive disorders are among the most common mental illnesses in children and adolescents and were already on the rise before the COVID-19 pandemic. This trend has been further exacerbated by the pandemic. Depression in adolescents is associated with particularly serious consequences, such as school and social problems, increased risk of suicide and impaired mental health in adulthood. If depression persists, the risk of chronification increases and continuous school attendance or continuation of vocational training is more difficult. The longer a depressive illness is not (effectively) treated, the lower the likelihood of remission and the higher the risk of chronification with further depressive episodes over the course of the illness. Although there are effective forms of treatment, in Germany only around 12% of adolescents with increased symptoms of depression seek professional treatment. The main barriers for adolescents to seek professional help include, for example, individual factors (low knowledge of mental disorders), social factors (e.g., perceived social stigmatisation) and systemic and structural barriers (e.g., limited access to professional help). In order to meet the need for action in a timely manner that meets the needs of the target group, the Department of Child and Adolescent Psychiatry of the Hospital of the LMU Munich and the Beisheim Foundation launched the innovative digital information portal "ich bin alles" ("I am everything"; www.ich-bin-alles.de) on depression and mental health in youth in 2021. Due to a sharp increase in online health information in recent years, the quality of this information and information portals has increasingly become the centre of attention. A review of the quality of mental health information websites found that many of the websites had shortcomings in terms of transparency, presentation and accuracy of content. These limitations were confirmed in a more recent study of depression websites. The comprehensibility of the content is also often limited, especially for users with a lower level of education and/or health literacy.

Due to the high relevance of comprehensively evaluating web-based information services on mental health and mental illness, the aim of this study is to use established methods to learn more about the visitors of "ich bin alles" and their user experience. This study will build on the approach of previous studies on website evaluation, which usually follow a multi-method approach: The evaluation of website analyses using tools such as Matomo; as well as an online questionnaire. The study is intended to provide clues as to whether the "ich bin alles" information platform is a useful and trustworthy source of information for the target groups. The information obtained is of central importance for potential adaptations and optimizations of the "ich bin alles" website. Another aim of this study is to determine whether "ich bin alles" can actually reach its desired target groups. The results of the data collection also provide an important basis for future approaches aimed at informing children, young people and their parents about mental health issues and mental illness in a way that is appropriate for the target group.

Study Type

Observational

Enrollment (Estimated)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

users of the website "ich bin alles"

Description

Inclusion Criteria:

  • 40 seconds website-use

Exclusion Criteria:

  • no exclusion criteria

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The characteristics of the people who are interested in "ich bin alles" (i.e. the users) - Assessed via self-designed questionnaire
Time Frame: post (40 seconds after Website-use)
post (40 seconds after Website-use)
Perception of the users of website content - Assessed via WEB-CLIC-S
Time Frame: post (40 seconds after Website-use)
post (40 seconds after Website-use)
Perceived Website Usability - Assessed via Perceived Website Usability - German
Time Frame: post (40 seconds after Website-use)
post (40 seconds after Website-use)
Visual Aesthetics of Website - Assessed via Visual Aesthetics of Website Inventory - Short
Time Frame: post (40 seconds after Website-use)
post (40 seconds after Website-use)
Overall impression - assessed via a single item (school grade)
Time Frame: post (40 seconds after Website-use)
post (40 seconds after Website-use)
Intentions to act - Assessed via Scale assessing the intention to revisit the website
Time Frame: post (40 seconds after Website-use)
post (40 seconds after Website-use)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
specific data collected for "ich bin alles" with Matomo
Time Frame: 45 months (from launch of the website until anticipated study completion)
Title of the pages accessed (page title)
45 months (from launch of the website until anticipated study completion)
specific data collected for "ich bin alles" with Matomo
Time Frame: 45 months (from launch of the website until anticipated study completion)
Location of the users: Country, region, city, approximate latitude and longitude (geolocation)
45 months (from launch of the website until anticipated study completion)
specific data collected for "ich bin alles" with Matomo
Time Frame: 45 months (from launch of the website until anticipated study completion)
Number of the website users
45 months (from launch of the website until anticipated study completion)
specific data collected for "ich bin alles" with Matomo
Time Frame: 45 months (from launch of the website until anticipated study completion)
How the users accessed the website (e.g. Google search or Social Media link)
45 months (from launch of the website until anticipated study completion)
specific data collected for "ich bin alles" with Matomo
Time Frame: 45 months (from launch of the website until anticipated study completion)
How much time the users spend on the website
45 months (from launch of the website until anticipated study completion)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Gerd Schulte-Körne, Prof. Dr., Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, LMU University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 20, 2024

Primary Completion (Estimated)

June 1, 2025

Study Completion (Estimated)

June 1, 2025

Study Registration Dates

First Submitted

September 27, 2024

First Submitted That Met QC Criteria

October 30, 2024

First Posted (Actual)

October 31, 2024

Study Record Updates

Last Update Posted (Actual)

October 31, 2024

Last Update Submitted That Met QC Criteria

October 30, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe